Woori IO, an OSR Company, Signs NDA with Sinopharm to Explore China Commercial Opportunities
Lakeside Signs $1.5 Million Sales Agreement with Sinopharm Group Subsidiary
Lakeside Strengthens Market Position in China's Pharmaceutical Logistics with Key Sinopharm(Hubei) Contracts
Pandemic Accelerates China's Drive Into mRNA Treatments
Week In Review: WHO Close To Approving Global Use For 2 China COVID-19 Vaccines
Diversifying Into Top-Ranked Sinopharm
Week In Review: Sinopharm Transfers $4.6 Billion In Assets Including Two COVID-19 Vaccines
Week In Review: Eluminex Raises $50 Million For Ophthalmology Drugs